Feb 19, 2020 by Brian Orelli, PhDFDA Approved 1,014 Generic Drugs in 2019Approvals were down slightly year over year.
Feb 19, 2020 by Brian Orelli, PhDFDA Rejects New Dosing for Merck's Cancer Drug KeytrudaThe old dosing regimen will still be available for patients.
Feb 19, 2020 by Brian Orelli, PhDIncyte's Ruxolitinib Works in Patients With EczemaThe biotech company just reported data from a pair of successful late-stage clinical trials.
Feb 18, 2020 by Brian Orelli, PhD17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of AllerganThe groups are worried about reduced competition if the merger goes through.
Feb 18, 2020 by Brian Orelli, PhDWant to Know What Your Heart Defibrillator Is Doing? Abbott Has an App for ThatRemote monitoring should help doctors and patients identify issues earlier.
Feb 18, 2020 by Brian Orelli, PhDPfizer Gains European Approval for Amyloidosis Drug VyndaqelSales of the treatment got off to a good start in the U.S., and Europe could follow suit.
Feb 18, 2020 by Brian Orelli, PhDSanofi Gets Backing From U.S. Government to Develop a COVID-19 VaccineThe French drugmaker joins a host of other companies trying to develop vaccines and treatments for the coronavirus.
Feb 18, 2020 by Brian Orelli, PhDJohnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19The government is also supporting the pharmaceutical giant's efforts to find a vaccine for the coronavirus.
Feb 17, 2020 by Brian Orelli, PhDFDA Approves 3 Drugs for the Switch From Prescription to Over the CounterThe switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.
Feb 17, 2020 by Brian Orelli, PhDThe FDA Has a Plan to Deal With the CoronavirusThe COVID-19 virus is putting a wrinkle in the agency's activities.
Feb 13, 2020 by Brian Orelli, PhDFDA Asks That Weight Loss Drug Belviq Be Pulled From the MarketA study finds an increased risk of cancer, and the manufacturer complies with the FDA's request.
Feb 13, 2020 by Brian Orelli, PhDWhite House Claims Other Countries Are "Free-Riding" on U.S. Drug DevelopmentIt's gotten worse over the last 15 years.
Feb 13, 2020 by Brian Orelli, PhDHere's Why Inovio Pharmaceuticals Stock Rocketed Higher TodayThe biotech could start testing its coronavirus vaccine as early as this summer.
Feb 13, 2020 by Brian Orelli, PhDFDA Gives Bristol-Myers Squibb's CAR-T Liso-Cel a Priority ReviewA decision on the cancer therapy is expected by Aug. 17.
Feb 12, 2020 by Brian Orelli, PhDEli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in EczemaThe drug moves closer to an expanded approval for the skin disorder.
Feb 12, 2020 by Brian Orelli, PhDFDA Confirms There's No Evidence That Cell Phones Cause CancerA new report from the agency reviewed nearly 200 studies published on the subject over more than a decade.
Feb 12, 2020 by Brian Orelli, PhDHere's Why Moderna Slipped Lower TodayA secondary offering causes dilution for the biotech.
Feb 12, 2020 by Brian Orelli, PhDMerck's Keytruda Helps Treat an Aggressive Form of Breast CancerAnother win for the seeming unstoppable drug -- this time in metastatic triple-negative breast cancer.
Feb 10, 2020 by Brian Orelli, PhDTrump Wants a New Agency to Oversee Tobacco ProductsThe move would strip the Food and Drug Administration of the duty it's held for more than a decade.
Feb 10, 2020 by Brian Orelli, PhDMyovant's Uterine Fibroid Drug Relugolix Produces Positive Data in a Long-Term StudyThe results were consistent with a pair of shorter studies of the combination treatment.
